On Friday, Hims & Hers Health Inc (NYSE: HIMS) opened lower -9.21% from the last session, before settling in for the closing price of $57.87. Price fluctuations for HIMS have ranged from $16.05 to $72.98 over the past 52 weeks.
A company in the Healthcare sector has jumped its sales by 17.22% annually for the last half of the decade. Company’s average yearly earnings per share was noted 7.72% at the time writing. With a float of $202.71 million, this company’s outstanding shares have now reached $217.38 million.
Hims & Hers Health Inc (HIMS) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Drug Manufacturers – Specialty & Generic industry is another important factor to consider. The insider ownership of Hims & Hers Health Inc is 10.33%, while institutional ownership is 77.77%. The most recent insider transaction that took place on Oct 01 ’25, was worth 14,000. In this transaction Chief Commercial Officer of this company sold 250 shares at a rate of $56.00, taking the stock ownership to the 291,439 shares. Before that another transaction happened on Oct 01 ’25, when Company’s Officer proposed sale 250 for $56.00, making the entire transaction worth $14,000.
Hims & Hers Health Inc (HIMS) Latest Financial update
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted 0.43 earnings per share (EPS) for the quarter, besting the agreed prediction (set at 0.15) by 0.28. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.26 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 7.72% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 25.47% during the next five years compared to 17.22% growth over the previous five years of trading.
Hims & Hers Health Inc (NYSE: HIMS) Trading Performance Indicators
Check out the current performance indicators for Hims & Hers Health Inc (HIMS). In the past quarter, the stock posted a quick ratio of 4.46. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.90. Likewise, its price to free cash flow for the trailing twelve months is 101.96.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.80, a number that is poised to hit 0.10 in the next quarter and is forecasted to reach 0.79 in one year’s time.
Technical Analysis of Hims & Hers Health Inc (HIMS)
Let’s dig in a bit further. During the last 5-days, its volume was 26.68 million. That was inferior than the volume of 32.76 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 49.48%.
During the past 100 days, Hims & Hers Health Inc’s (HIMS) raw stochastic average was set at 39.66%, which indicates a significant increase from 32.46% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 3.66 in the past 14 days, which was lower than the 3.84 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $51.77, while its 200-day Moving Average is $43.90. However, in the short run, Hims & Hers Health Inc’s stock first resistance to watch stands at $56.81. Second resistance stands at $61.08. The third major resistance level sits at $63.23. If the price goes on to break the first support level at $50.39, it is likely to go to the next support level at $48.24. The third support level lies at $43.97 if the price breaches the second support level.
Hims & Hers Health Inc (NYSE: HIMS) Key Stats
There are currently 226,020K shares outstanding in the company with a market cap of 11.88 billion. Presently, the company’s annual sales total 1,477 M according to its annual income of 126,040 K. Last quarter, the company’s sales amounted to 544,830 K and its income totaled 42,510 K.
